4.8 Article

A Critical Role for LTA4H in Limiting Chronic Pulmonary Neutrophilic Inflammation

期刊

SCIENCE
卷 330, 期 6000, 页码 90-94

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1190594

关键词

-

资金

  1. Wellcome Trust [082727/Z/07/Z]
  2. National Heart, Lung, and Blood Institute [HL07783, HL090999, HL087824, HL102371-A1, K08HL091127]
  3. Cystic Fibrosis Foundation [GAGGAR07]
  4. National Institute of Diabetes and Digestive and Kidney Diseases [1K23DK075788, 1R03DK084110-01]
  5. Flight Attendant Medical Research Institute
  6. Medical Research Council [P171/03/C1/048]
  7. NIH [RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, P30 DK079337]
  8. Wellcome Trust [082727/Z/07/Z] Funding Source: Wellcome Trust
  9. Medical Research Council [G0400795, G0802752] Funding Source: researchfish
  10. National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish
  11. MRC [G0400795, G0802752] Funding Source: UKRI

向作者/读者索取更多资源

Leukotriene A(4) hydrolase (LTA(4)H) is a proinflammatory enzyme that generates the inflammatory mediator leukotriene B-4 (LTB4). LTA(4)H also possesses aminopeptidase activity with unknown substrate and physiological importance; we identified the neutrophil chemoattractant proline-glycine-proline (PGP) as this physiological substrate. PGP is a biomarker for chronic obstructive pulmonary disease (COPD) and is implicated in neutrophil persistence in the lung. In acute neutrophil-driven inflammation, PGP was degraded by LTA(4)H, which facilitated the resolution of inflammation. In contrast, cigarette smoke, a major risk factor for the development of COPD, selectively inhibited LTA(4)H aminopeptidase activity, which led to the accumulation of PGP and neutrophils. These studies imply that therapeutic strategies inhibiting LTA(4)H to prevent LTB4 generation may not reduce neutrophil recruitment because of elevated levels of PGP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据